Correlation Between IShares Global and IShares Biotechnology
Can any of the company-specific risk be diversified away by investing in both IShares Global and IShares Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Global and IShares Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Global Healthcare and iShares Biotechnology ETF, you can compare the effects of market volatilities on IShares Global and IShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Global with a short position of IShares Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Global and IShares Biotechnology.
Diversification Opportunities for IShares Global and IShares Biotechnology
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between IShares and IShares is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding iShares Global Healthcare and iShares Biotechnology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Biotechnology ETF and IShares Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Global Healthcare are associated (or correlated) with IShares Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Biotechnology ETF has no effect on the direction of IShares Global i.e., IShares Global and IShares Biotechnology go up and down completely randomly.
Pair Corralation between IShares Global and IShares Biotechnology
Considering the 90-day investment horizon iShares Global Healthcare is expected to generate 0.63 times more return on investment than IShares Biotechnology. However, iShares Global Healthcare is 1.58 times less risky than IShares Biotechnology. It trades about 0.03 of its potential returns per unit of risk. iShares Biotechnology ETF is currently generating about 0.02 per unit of risk. If you would invest 8,414 in iShares Global Healthcare on August 30, 2024 and sell it today you would earn a total of 797.00 from holding iShares Global Healthcare or generate 9.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
iShares Global Healthcare vs. iShares Biotechnology ETF
Performance |
| Timeline |
| iShares Global Healthcare |
| iShares Biotechnology ETF |
IShares Global and IShares Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IShares Global and IShares Biotechnology
The main advantage of trading using opposite IShares Global and IShares Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Global position performs unexpectedly, IShares Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Biotechnology will offset losses from the drop in IShares Biotechnology's long position.| IShares Global vs. iShares Global Financials | IShares Global vs. iShares Global Tech | IShares Global vs. iShares Global Comm | IShares Global vs. iShares Healthcare ETF |
| IShares Biotechnology vs. First Trust Exchange Traded | IShares Biotechnology vs. Ultimus Managers Trust | IShares Biotechnology vs. Horizon Kinetics Medical | IShares Biotechnology vs. Harbor Health Care |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |